checkAd
    Startseite > Aktien > ORIC Pharmaceuticals > Nachrichten
    ORIC Pharmaceuticals Aktie
    8,8300
     
    USD
    +7,29 %
    +0,6000 USD
    Letzter Kurs 02:00:00 Nasdaq
    8,8300
     
    USD
    6.700 STK
    Geldkurs 30.04.24
    8,8500
     
    USD
    100 STK
    Briefkurs 30.04.24
    ISIN: US68622P1093 · WKN: A2P208 · SYM: ORIC · USA

    Neueste Nachrichten

    ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
    15.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    08.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    05.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    04.04.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
    11.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
    06.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    05.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    01.03.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
    14.02.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    02.02.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
    31.01.24 · globenewswire · ORIC Pharmaceuticals
    ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
    22.01.24 · globenewswire · ORIC Pharmaceuticals